Stay updated on Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page.

Latest updates to the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoChange DetectedThe page has added a section with helpful links provided by Pfizer, specifically directing users to obtain contact information for a study center nearby.SummaryDifference0.4%
- Check23 days agoChange DetectedThe page has been updated to include new information about atopic dermatitis and a new revision number, while significant details about the study's design and criteria have been removed.SummaryDifference5%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting NLM-NCBI services and a link to obtain contact information for a study center provided by Pfizer.SummaryDifference1%
Stay in the know with updates to Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page.